This Article Full Text Full Text (PDF) All Versions of this Article: 106/1/124    most recent 01.CIR.0000020220.79105.FDv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tevaearai, H. T. Articles by Koch, W. J. Search for Related Content PubMed PubMed Citation Articles by Tevaearai, H. T. Articles by Koch, W. J. Pubmed/NCBI databases Medline Plus Health Information Genes and Gene Therapy Heart Failure Related Collections Gene expression Heart failure - basic studies

(Circulation. 2002;106:124.)
© 2002 American Heart Association, Inc.

Basic Science Reports

Myocardial Gene Transfer and Overexpression of ß₂-Adrenergic Receptors Potentiates the Functional Recovery of Unloaded Failing Hearts

Hendrik T. Tevaearai, MD; Andrea D. Eckhart, PhD; G. Brant Walton, BS; Janelle R. Keys, PhD; Katrina Wilson, BS; Walter J. Koch, PhD

From the Departments of Surgery (H.T.T., A.D.E., G.B.W., W.J.K.) and Medicine (K.W.), Duke University Medical Center, Durham, NC. Dr Tevaearai is now at the Department of Cardiovascular Surgery, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.

Correspondence to Walter J. Koch, PhD, Box 2606, Duke University Medical Center, Durham, NC 27710. E-mail koch0002{at}mc.duke.edu

Background— Mechanical assistance of the failing left ventricle (LV) can lead to functional recovery after a period of unloading, including restoration of ß-adrenergic receptor (ßAR) inotropic reserve. We tested whether prolonged LV unloading of failing rabbit hearts by use of a heterotopic transplantation technique could lead to recovery and whether adenoviral gene transfer of a ß₂AR transgene (Adv-ß₂AR) could alter this process.

Methods and Results— Heart failure was induced by coronary artery ligation in adult New Zealand White rabbits. After 4 weeks, failing hearts were heterotopically transplanted into recipient rabbits, allowing normal coronary perfusion but complete LV unloading. We also placed an LV latex balloon for remote access and in vivo physiological analysis. We found that there was reversal of signaling and functional abnormalities after 30 days of unloading. In another set of failing hearts, we randomly delivered, at the time of transplantation, either 2x10¹¹ viral particles of Adv-ß₂AR or saline via the coronary arteries. Sham-operated animals with nonfailing hearts served as controls. After 5 days of unloading, in vivo LV contractility (LV dP/dt_max) and relaxation (LV dP/dt_min) were significantly decreased in saline-treated failing hearts compared with control nonfailing hearts (P<0.05). In failing hearts treated with Adv-ß₂AR, however, LV dP/dt_max and LV dP/dt_min were improved in response to higher preloads (P<0.05) and ßAR stimulation (P<0.01).

Conclusions— Heterotopic transplantation in the rabbit does allow recovery of the failing heart, and ß₂AR overexpression acutely enhances this functional improvement. Accordingly, genetic manipulation of ßAR signaling may represent a novel molecular adjunct to mechanical assistance to facilitate functional myocardial recovery.

Key Words: heart failure • receptors, adrenergic, beta • remodeling • heart-assist device • gene therapy

This article has been cited by other articles:

				L. E. Vinge, P. W. Raake, and W. J. Koch Gene Therapy in Heart Failure Circ. Res., June 20, 2008; 102(12): 1458 - 1470. [Abstract] [Full Text] [PDF]

				G. K.R. Soppa, J. Lee, M. A. Stagg, L. E. Felkin, P. J.R. Barton, U. Siedlecka, S. Youssef, M. H. Yacoub, and C. M.N. Terracciano Role and possible mechanisms of clenbuterol in enhancing reverse remodelling during mechanical unloading in murine heart failure Cardiovasc Res, March 1, 2008; 77(4): 695 - 706. [Abstract] [Full Text] [PDF]

				E. J. Birks, P. D. Tansley, J. Hardy, R. S. George, C. T. Bowles, M. Burke, N. R. Banner, A. Khaghani, and M. H. Yacoub Left Ventricular Assist Device and Drug Therapy for the Reversal of Heart Failure N. Engl. J. Med., November 2, 2006; 355(18): 1873 - 1884. [Abstract] [Full Text] [PDF]

				B. Pieske Reverse remodeling in heart failure - fact or fiction? Eur. Heart J. Suppl., August 1, 2004; 6(suppl_D): D66 - D78. [Abstract] [Full Text] [PDF]

				J.R. Keys and W.J. Koch The Adrenergic Pathway and Heart Failure Recent Prog. Horm. Res., January 1, 2004; 59(1): 13 - 30. [Abstract] [Full Text]

				Y. Yue, Z. Li, S. Q. Harper, R. L. Davisson, J. S. Chamberlain, and D. Duan Microdystrophin Gene Therapy of Cardiomyopathy Restores Dystrophin-Glycoprotein Complex and Improves Sarcolemma Integrity in the Mdx Mouse Heart Circulation, September 30, 2003; 108(13): 1626 - 1632. [Abstract] [Full Text] [PDF]

				J. K. F. Hon and M. H. Yacoub Bridge to recovery with the use of left ventricular assist device and clenbuterol Ann. Thorac. Surg., June 1, 2003; 75(90060): S36 - 41. [Abstract] [Full Text] [PDF]

				K. Ito, M. Nakayama, F. Hasan, X. Yan, M. D. Schneider, and B. H. Lorell Contractile Reserve and Calcium Regulation Are Depressed in Myocytes From Chronically Unloaded Hearts Circulation, March 4, 2003; 107(8): 1176 - 1182. [Abstract] [Full Text] [PDF]

				H. T. Tevaearai, G. B. Walton, A. D. Eckhart, J. R. Keys, and W. J. Koch Donor heart contractile dysfunction following prolonged ex vivo preservation can be prevented by gene-mediated {beta}-adrenergic signaling modulation Eur. J. Cardiothorac. Surg., November 1, 2002; 22(5): 733 - 737. [Abstract] [Full Text] [PDF]